A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Clinical trial NCT02287922 · COMPLETED

Trial details

NCT number: NCT02287922
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2015-03-01
Primary completion: 2016-07-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.